-
1
-
-
0023575637
-
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial
-
Fu KK, Phillips TL, Silverberg IJ, et al., Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-1418.
-
(1987)
J Clin Oncol
, vol.5
, pp. 1410-1418
-
-
Fu, K.K.1
Phillips, T.L.2
Silverberg, I.J.3
-
2
-
-
0037208591
-
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemotherapy in patients with unresectable squamous cell head and neck cancer
-
Adelstein DJ, Li Y, Adams GL, et al., An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98.
-
(2003)
J Clin Oncol
, vol.21
, pp. 92-98
-
-
Adelstein, D.J.1
Li, Y.2
Adams, G.L.3
-
3
-
-
51449093748
-
Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: Phase I-II clinical study
-
Strojan P, Karner K, Smid L, et al., Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study. Int J Radiat Oncol Biol Phys 2008; 72: 365-372.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 365-372
-
-
Strojan, P.1
Karner, K.2
Smid, L.3
-
4
-
-
80051781309
-
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV local advanced HNSCC: Results of a GORTEC randomized trial
-
Bourhis J, Lapeyre M, Tortochaux J, et al., Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV local advanced HNSCC: results of a GORTEC randomized trial. Radiother Oncol 2011; 100: 56-61.
-
(2011)
Radiother Oncol
, vol.100
, pp. 56-61
-
-
Bourhis, J.1
Lapeyre, M.2
Tortochaux, J.3
-
5
-
-
35548966042
-
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
-
Vermorken JB, Remenar E, van Herpen C, et al., Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-1704.
-
(2007)
N Engl J Med
, vol.357
, pp. 1695-1704
-
-
Vermorken, J.B.1
Remenar, E.2
Van Herpen, C.3
-
6
-
-
35548972994
-
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
-
Posner MR, Hershock DM, Blajman CR, et al., Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-1715.
-
(2007)
N Engl J Med
, vol.357
, pp. 1705-1715
-
-
Posner, M.R.1
Hershock, D.M.2
Blajman, C.R.3
-
7
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
Bonner JA, Harari PM, Giralt J, et al., Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
8
-
-
77956266565
-
A review of the clinical evidence for intensity-modulated radiotherapy
-
Radiotherapy Development Board
-
Staffurth J,; Radiotherapy Development Board. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010; 22: 643-657.
-
(2010)
Clin Oncol (R Coll Radiol)
, vol.22
, pp. 643-657
-
-
Staffurth, J.1
-
9
-
-
84939216393
-
A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers
-
Kumar S, Sriram P, Saranya K, Bhuvaneswari N, Vivekanandan N,. A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers. Int J Radiat Oncol Biol Phys 2010; 78 (Suppl): S836-S837.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.78
, pp. S836-S837
-
-
Kumar, S.1
Sriram, P.2
Saranya, K.3
Bhuvaneswari, N.4
Vivekanandan, N.5
-
10
-
-
26444450999
-
ConPas: A 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT
-
Wiggenraad R, Mast M, van Santvoort J, Hoogendoorn M, Struikmans H,. ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005; 181: 673-682.
-
(2005)
Strahlenther Onkol
, vol.181
, pp. 673-682
-
-
Wiggenraad, R.1
Mast, M.2
Van Santvoort, J.3
Hoogendoorn, M.4
Struikmans, H.5
-
11
-
-
39049165254
-
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
-
Bernier J, Bonner J, Vermorken JB, et al., Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008; 19: 142-149.
-
(2008)
Ann Oncol
, vol.19
, pp. 142-149
-
-
Bernier, J.1
Bonner, J.2
Vermorken, J.B.3
-
12
-
-
80855132770
-
In inverted papillomas HPV more likely represents incidental colonization than an etiological factor
-
Jenko K, Kocjan B, Zidar N, et al., In inverted papillomas HPV more likely represents incidental colonization than an etiological factor. Virchows Arch 2011; 459: 529-538.
-
(2011)
Virchows Arch
, vol.459
, pp. 529-538
-
-
Jenko, K.1
Kocjan, B.2
Zidar, N.3
-
13
-
-
0035970795
-
Sample size tables for exact single-stage phase II designs
-
A'Hern RP,. Sample size tables for exact single-stage phase II designs. Stat Med 2001; 20: 859-866.
-
(2001)
Stat Med
, vol.20
, pp. 859-866
-
-
A'Hern, R.P.1
-
14
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
15
-
-
0017365573
-
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
-
Peto R, Pike MC, Armitage P, et al., Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
-
(1977)
Br J Cancer
, vol.35
, pp. 1-39
-
-
Peto, R.1
Pike, M.C.2
Armitage, P.3
-
16
-
-
84865317847
-
DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN)
-
(abstr 5500)
-
Cohen EEW, Karrison T, Kocherginsky M, et al., DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 2012; 30 (Suppl 15): 356s (abstr 5500).
-
(2012)
J Clin Oncol
, vol.30
, pp. 356s
-
-
Cohen, E.E.W.1
Karrison, T.2
Kocherginsky, M.3
-
17
-
-
84875267472
-
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
-
Haddad R, O'Neill A, Rabinowits G, et al., Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 2013; 14: 257-264.
-
(2013)
Lancet Oncol
, vol.14
, pp. 257-264
-
-
Haddad, R.1
O'Neill, A.2
Rabinowits, G.3
-
18
-
-
84867893188
-
The future of induction chemotherapy for head and neck squamous cell carcinoma
-
Haigentz M Jr, Cohen EE, Wolf GT, Strojan P, Eisbruch A, Ferlito A,. The future of induction chemotherapy for head and neck squamous cell carcinoma. Oral Oncol 2012; 48: 1065-1067.
-
(2012)
Oral Oncol
, vol.48
, pp. 1065-1067
-
-
Haigentz, Jr.M.1
Cohen, E.E.2
Wolf, G.T.3
Strojan, P.4
Eisbruch, A.5
Ferlito, A.6
-
19
-
-
84875264233
-
Chemoradiotherapy vs. Total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma
-
Strojan P, Haigentz M Jr, Bradford CR, et al., Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol 2012; 49: 283-286.
-
(2012)
Oral Oncol
, vol.49
, pp. 283-286
-
-
Strojan, P.1
Haigentz, Jr.M.2
Bradford, C.R.3
-
20
-
-
84873825096
-
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial
-
Mesía R, Rueda A, Vera R, et al., Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol 2013; 24: 448-453.
-
(2013)
Ann Oncol
, vol.24
, pp. 448-453
-
-
Mesía, R.1
Rueda, A.2
Vera, R.3
-
21
-
-
73249143536
-
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
-
Bonner JA, Harari PM, Giralt J, et al., Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21-28.
-
(2010)
Lancet Oncol
, vol.11
, pp. 21-28
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
22
-
-
51649085865
-
Platinum-based chemotherapy plus cetuximab in head and neck cancer
-
Vermorken JB, Mesia R, Rivera F, et al., Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008; 359: 1116-1127.
-
(2008)
N Engl J Med
, vol.359
, pp. 1116-1127
-
-
Vermorken, J.B.1
Mesia, R.2
Rivera, F.3
-
23
-
-
78249251774
-
Head and neck cancer: Proteomic advances and biomarker achievements
-
Rezende TM, de Souza Freire M, Franco OL,. Head and neck cancer: proteomic advances and biomarker achievements. Cancer 2010; 116: 4914-4925.
-
(2010)
Cancer
, vol.116
, pp. 4914-4925
-
-
Rezende, T.M.1
De Souza Freire, M.2
Franco, O.L.3
-
24
-
-
79952027751
-
Image cytometric nuclear texture features in inoperable head and neck cancer: A pilot study
-
Strojan-Flezar M, Lavrencak J, Zganec M, Strojan P,. Image cytometric nuclear texture features in inoperable head and neck cancer: a pilot study. Radiol Oncol 2011; 45: 40-45.
-
(2011)
Radiol Oncol
, vol.45
, pp. 40-45
-
-
Strojan-Flezar, M.1
Lavrencak, J.2
Zganec, M.3
Strojan, P.4
-
25
-
-
34548487155
-
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
-
O'Neil BH, Allen R, Spigel DR, et al., High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. J Clin Oncol 2007; 25: 3644-3648.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3644-3648
-
-
O'Neil, B.H.1
Allen, R.2
Spigel, D.R.3
-
26
-
-
77953053076
-
Managing cetuximab hypersensitivity-infusion reactions: Incidence, risk factors, prevention, and retreatment
-
George TJ Jr, Laplant KD, Walden EO, et al., Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment. J Support Oncol 2010; 8: 72-77.
-
(2010)
J Support Oncol
, vol.8
, pp. 72-77
-
-
George, Jr.T.J.1
Laplant, K.D.2
Walden, E.O.3
-
27
-
-
79960517479
-
Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center
-
Hansen NL, Chandiramani DV, Morse MA, Wei D, Hedrick NE, Hansen RA,. Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center. J Oncol Pharm Pract 2011; 17: 125-130.
-
(2011)
J Oncol Pharm Pract
, vol.17
, pp. 125-130
-
-
Hansen, N.L.1
Chandiramani, D.V.2
Morse, M.A.3
Wei, D.4
Hedrick, N.E.5
Hansen, R.A.6
-
28
-
-
33644971314
-
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm
-
Pfister DG, Su YB, Kraus DH, et al., Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 2006; 24: 1072-1078.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1072-1078
-
-
Pfister, D.G.1
Su, Y.B.2
Kraus, D.H.3
-
29
-
-
84860448909
-
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma
-
Ma BB, Kam MK, Leung SF, et al., A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma. Ann Oncol 2012; 23: 1287-1292.
-
(2012)
Ann Oncol
, vol.23
, pp. 1287-1292
-
-
Ma, B.B.1
Kam, M.K.2
Leung, S.F.3
-
30
-
-
79951861341
-
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer
-
Argiris A, Heron DE, Smith RP, et al., Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol 2010; 28: 5294-5300.
-
(2010)
J Clin Oncol
, vol.28
, pp. 5294-5300
-
-
Argiris, A.1
Heron, D.E.2
Smith, R.P.3
-
31
-
-
77958486627
-
Phase i trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
-
Kuhnt T, Sandner A, Wendt T, et al., Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol 2010; 21: 2284-2289.
-
(2010)
Ann Oncol
, vol.21
, pp. 2284-2289
-
-
Kuhnt, T.1
Sandner, A.2
Wendt, T.3
-
32
-
-
84862817048
-
Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study
-
Wang ZH, Zhang SZ, Zhang ZY, et al., Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. Laryngoscope 2012; 122: 291-298.
-
(2012)
Laryngoscope
, vol.122
, pp. 291-298
-
-
Wang, Z.H.1
Zhang, S.Z.2
Zhang, Z.Y.3
-
33
-
-
79151484611
-
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial
-
Nutting CM, Morden JP, Harrington KJ, et al., Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.
-
(2011)
Lancet Oncol
, vol.12
, pp. 127-136
-
-
Nutting, C.M.1
Morden, J.P.2
Harrington, K.J.3
-
34
-
-
84894256986
-
Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: An evidence-based review
-
[Epub ahead of print]
-
Paleri V, Roe JW, Strojan P, et al., Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 2013 [Epub ahead of print].
-
(2013)
Head Neck
-
-
Paleri, V.1
Roe, J.W.2
Strojan, P.3
-
35
-
-
81855184870
-
Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck
-
Levy AR, Johnston KM, Sambrook J, et al., Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck. Curr Med Res Opin 2011; 27: 2253-2259.
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 2253-2259
-
-
Levy, A.R.1
Johnston, K.M.2
Sambrook, J.3
-
36
-
-
44449161951
-
Locoregionally advanced head and neck cancer treated with primary radiotherapy: A comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment
-
Caudell JJ, Sawrie SM, Spencer SA, et al., Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys 2008; 71: 676-681.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 676-681
-
-
Caudell, J.J.1
Sawrie, S.M.2
Spencer, S.A.3
-
37
-
-
80255134559
-
Concurrent cisplatin and radiotherapy versus cetuximab and radiation for locally advanced head-and-neck cancer
-
Koutcher L, Sherman E, Fury M, et al., Concurrent cisplatin and radiotherapy versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011; 81: 915-922.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 915-922
-
-
Koutcher, L.1
Sherman, E.2
Fury, M.3
-
38
-
-
78651368497
-
Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
-
Walsh L, Gillham C, Dunne M, et al., Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC). Radiother Oncol 2011; 98: 38-41.
-
(2011)
Radiother Oncol
, vol.98
, pp. 38-41
-
-
Walsh, L.1
Gillham, C.2
Dunne, M.3
-
39
-
-
79961128389
-
Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT
-
Studer G, Brown M, Salgueiro EB, et al., Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys 2011; 81: 110-117.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 110-117
-
-
Studer, G.1
Brown, M.2
Salgueiro, E.B.3
-
40
-
-
69949157387
-
Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
-
Zhang N, Erjala K, Kulmala J, et al., Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro. Radiother Oncol 2009; 92: 388-392.
-
(2009)
Radiother Oncol
, vol.92
, pp. 388-392
-
-
Zhang, N.1
Erjala, K.2
Kulmala, J.3
-
41
-
-
80053368876
-
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinoma (HNC)
-
(abstr 5500)
-
Ang KK, Zhang QE, Rosenthal DI, et al., A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinoma (HNC). J Clin Oncol 2011; 29 (Suppl): 360s (abstr 5500).
-
(2011)
J Clin Oncol
, vol.29
, pp. 360s
-
-
Ang, K.K.1
Zhang, Q.E.2
Rosenthal, D.I.3
|